DUBLIN, June 29, 2022 / PRNewswire / – The “Point-of-Care Glucose Testing Market Size, Share & Trends Analysis Report by Product (Accu-Chek Inform II, Freestyle Lite), by Region (North America, EuropeAPAC, LATAM, MEA), and Segment Forecasts, 2022-2030 “report has been added to ResearchAndMarkets.com’s offering.
The global point-of-care glucose testing market size is expected to reach USD 4.5 billion by 2030, growing at a CAGR of 4.1% over the forecast period. An increase in the demand for Point-of-Care Testing (POCT) has been witnessed in recent years.
As compared to the conventional laboratory testing performed in central lab settings, glucose POCT aids in performing effective diagnosis at the patient’s bedside. The easy and convenient operation of POCT has largely favored the growing usage of glucose meters across medical settings.
The demand for performing bedside monitoring of blood sugar levels efficiently in a capillary blood sample and the need to ensure better management of carbohydrate metabolism have propelled the companies to launch innovative glucose meters in the market.
Point-of-Care Glucose Testing Market Report Highlights
Accu-Chek Inform II accounted for the largest revenue share in 2021 and is anticipated to maintain this trend throughout the forecast period.
Bayer Contour blood glucose monitoring system is set to grow at a CAGR of 6.1% from 2022 to 2030.
North America is the leading regional market due to the higher penetration of novel diagnostic techniques.
Asia Pacific is estimated to register the fastest CAGR owing to the ever-increasing prevalence of diabetes and numerous untapped growth opportunities in diagnostics.
Moreover, a robust network of local manufacturers has significantly contributed to the revenue generated in this region.
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Point-of-Care (POC) Glucose Testing Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related / ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
184.108.40.206. Introduction of CLIA waived tests
220.127.116.11. Growing prevalence of diabetes
18.104.22.168. Rising demand for short turnaround time glucose POC testing
3.4.2. Market restraint analysis
22.214.171.124. Potential interference and calibration issues in glucose meters
126.96.36.199. Presence of ambiguous regulatory as well as reimbursement framework
3.5. Point-of-Care (POC) Glucose Testing Market Analysis Tools
3.5.1. Industry Analysis-Porter’s
188.8.131.52. Supplier power
184.108.40.206. Buyer power
220.127.116.11. Substitution threat
18.104.22.168. Threat of new entrant
22.214.171.124. Competitive rivalry
3.5.2. PESTEL Analysis
126.96.36.199. Political landscape
188.8.131.52. Technological landscape
184.108.40.206. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Point-of-Care (POC) Glucose Testing Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Accu-Check Aviva Meter
4.1.2. Onetouch Verio Flex
4.1.4. Freestyle Lite
4.1.5. Bayer CONTOUR Blood Glucose Monitoring System
4.1.6. True Metrix
4.1.7. Accu-Check Inform II
4.2. Product Market Share, 2018 & 2030
4.3. Dashboard segment
4.4. Point-of-Care (POC) Glucose Testing Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyzes, 2018 to 2030 for the following
4.5.1. Accu-Check Aviva Meter
220.127.116.11. Accu-Check Aviva Meter market estimates and forecast, 2018-2030
4.5.2. Onetouch Verio Flex
18.104.22.168. Onetouch Verio Flex market estimates and forecast, 2018-2030
22.214.171.124. STAT market estimates and forecast, 2018-2030
4.5.4. Freestyle Lite
126.96.36.199. Freestyle Lite market estimates and forecast, 2018-2030
4.5.5. Bayer Contour Blood Glucose Monitoring System
188.8.131.52. Bayer Contour Blood Glucose Monitoring System market estimates and forecast, 2018-2030
4.5.6. True Metrix
184.108.40.206. TRUE METRIX market estimates and forecast, 2018-2030
4.5.7. Accu-Check Inform II
220.127.116.11. Accu-Check Inform II market estimates and forecast, 2018-2030
18.104.22.168. StatStrip market estimates and forecast, 2018-2030
22.214.171.124. Others market estimates and forecast, 2018-2030
Chapter 5. Point-of-Care (POC) Glucose Testing Market: Regional Estimates & Trend Analysis
Chapter 6. Competitive Landscape
F. Hoffmann-La Roche Ltd.
PlatInium Equity Advisors, LLC (Lifescan, Inc.)
Trividia Health, Inc.
Prodigy Diabetes Care, LLC
Bayer AG / Ascensia Diabetes Care Holdings AG
For more information about this report visit https://www.researchandmarkets.com/r/77z0vw
Research and Markets
Laura WoodSenior Manager
For EST Office Hours Call + 1-917-300-0470
For US / CAN Toll Free Call + 1-800-526-8630
For GMT Office Hours Call + 353-1-416-8900
US Fax: 646-607-1904
Fax (outside US): + 353-1-481-1716
View original content: https: //www.prnewswire.com/news-releases/point-of-care-glucose-testing-market-report-2022-2030-featuring-key-players-abbott-nova-biomedical-trividia- health – more-301578102.html
SOURCE Research and Markets